Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China.
Wang QuZimin LiuXiaobing ChenBo LiuYunBo ZhaoHao YanXiujuan QuShengmian LiAimin ZangYongkun SunLiangjun ZhuAiping ZhouPublished in: BMC cancer (2024)
ClinicalTrials.gov Identifier: NCT04835324. Registered 6th April 2021.